Markets

Insider Trading

Hedge Funds

Retirement

Opinion

11 Cheap Pot Stocks to Buy

In this article, we discuss the 11 cheap pot stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to 5 Cheap Pot Stocks to Buy.

As with any nascent industry, the pot industry around the world has been facing a plethora of challenges and opportunities over the past few months. In the United States and Europe, the focus of investors remains on key policy reform around the legalization of marijuana. There are even countries in South America and Asia that are considering cannabis mainstreaming. In Canada, where the pot industry is flourishing, investors are now looking towards mergers and acquisition activity, as well as a rightsizing of the market, to place their bets. 

According to a report by Fortune Business Insights, the global cannabis market is expected to grow at a compound annual rate of more than 34% in the next five years, expanding from $57 billion in size to more than $444 billion. Rami El-Cheikh, a top partner at strategy consulting firm EY Pantheon, recently told finance news platform INN that access to capital markets remains a key concern for many cannabis firms heading into 2024. Per Cheikh, the capital markets in the United States will play an important role in cannabis growth. 

“I think there’s going to be more acceleration of bankruptcies and restructurings in 2024. I think the balance sheets are very stretched. So that’s going to be very problematic, and (even though) a lot of the cannabis companies have been very active with their cost-reduction programs, I don’t know to what extent they can further reduce costs and further streamline their operations. They’ve been at it for about a year or two years now. So without improved capital markets (or) competitors exiting the market, it’s going to continue to be a challenging, challenging industry.”

Even though the challenges remain, companies like Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON) are writing their own growth stories. Mike Gorenstein, the executive chairman of Cronos Group Inc. (NASDAQ:CRON), said during a recent earnings call that even though his company was focused on growing in established markets, it had already begun exploring ways to increase presence in emerging cannabis markets like Germany and Australia. 

“We continue to have an industry-leading balance sheet with a cash and short-term investment balance of approximately $840 million. The strength of our balance sheet is supported by improved gross margin, lower operating expenses, robust interest income, and improved working capital management. We intend to build on this momentum for the remainder of the year and into 2024 as we realize P&L efficiencies and additional interest income from our cash and short-term investments. In September, we sent our first order of cannabis to our German distribution partner, Cansativa, and we are very excited to bring the Peace Naturals brand back to the German market.

Cansativa is one of the leading distributors of medical cannabis in Germany and has a network of approximately 2,000 high-volume cannabis-focused pharmacies that currently supply around 300,000 patients. Re-entering the German market, which has about 83 million people, is a significant milestone for us. We are working closely with the Cansativa sales team, who are excited about selling this brand in the market. Traction in the early innings of our launch is strong and Cansativa has already received significant orders of Peace Naturals.

Our goal is to continue to expand our reach and brand awareness in Germany with the help of Cansativa to establish our Peace Naturals brand as a top medical brand, similar to the brand’s reputation in other international markets. Re-establishing Cronos and our Peace Naturals brand in the German market will position us to capitalize on this growing opportunity with additional upside potential from future legislative changes, including in the event the German government reschedules cannabis and no longer labels cannabis as a narcotic. Turning to Australia, we are in the process of filing our first order to Vitura with the first shipment to Australia planned to go out later this month. As a reminder, Cronos owns approximately 10% of the common shares of Vitura.”

Our Methodology

The companies that operate in the pot sector and were priced under $3 per share, as of December 26, were selected for the list and ranked according to hedge fund sentiment. Data from around 900 elite hedge funds tracked by Insider Monkey in the third quarter of 2023 was used to identify the number of hedge funds that hold stakes in each firm. Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). That’s why we pay very close attention to this often-ignored indicator.

A doctor in a lab coat discussing the potential complexities of treating cancer with cannabinoid medicines.

Cheap Pot Stocks to Buy

11. SNDL Inc. (NASDAQ:SNDL)

Number of Hedge Fund Holders: 3    

Real Time Share Price as of December 26: $1.54  

SNDL Inc. (NASDAQ:SNDL) is a Canada-based firm that markets cannabis products. On November 13, SNDL Inc. (NASDAQ:SNDL) posted earnings for the third quarter of 2023, reporting a revenue of C$237 million, up more than 3% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 3 hedge funds in the database of Insider Monkey held stakes worth $1.3 million in SNDL Inc. (NASDAQ:SNDL), compared to 2 the preceding quarter worth $1.2 million.

Just like Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON), SNDL Inc. (NASDAQ:SNDL) is one of the cheap pot stocks to buy. 

10. Village Farms International, Inc. (NASDAQ:VFF)

Number of Hedge Fund Holders: 4 

Real Time Share Price as of December 26: $0.76

Village Farms International, Inc. (NASDAQ:VFF) markets agricultural products. On November 9, investment advisory Craig-Hallum upgraded Village Farms International, Inc. (NASDAQ:VFF) stock to Buy from Hold with a price target of $1. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $243,000 in Village Farms International, Inc. (NASDAQ:VFF), compared to 5 in the preceding quarter worth $250,000. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in Village Farms International, Inc. (NASDAQ:VFF) with 209,995 shares worth more than $167,000. 

9. Clever Leaves Holdings Inc. (NASDAQ:CLVR)

Number of Hedge Fund Holders: 4  

Real Time Share Price as of December 26: $2.20

Clever Leaves Holdings Inc. (NASDAQ:CLVR) operates in the botanical cannabinoid and nutraceutical industries. On November 9, Clever Leaves Holdings Inc. (NASDAQ:CLVR) posted earnings for the third quarter of 2023, reporting a revenue of $3.8 million, up more than 15% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $10,000 in  Clever Leaves Holdings Inc. (NASDAQ:CLVR), compared to 6 in the previous quarter worth $351,000.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Renaissance Technologies is a leading shareholder in Clever Leaves Holdings Inc. (NASDAQ:CLVR) with 28,489 shares worth more than $98,000. 

8. Organigram Holdings Inc. (NASDAQ:OGI)

Number of Hedge Fund Holders: 4   

Real Time Share Price as of December 26: $1.26

Organigram Holdings Inc. (NASDAQ:OGI) engages in the production and sale of cannabis and cannabis-derived products in Canada. On December 19, Organigram Holdings Inc. (NASDAQ:OGI) posted earnings for the fourth fiscal quarter, reporting a revenue of C$46 million, up over 1% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $336,000 in Organigram Holdings Inc. (NASDAQ:OGI), compared to 5 in the previous quarter worth $808,000.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm DE Shaw is a leading shareholder in Organigram Holdings Inc. (NASDAQ:OGI) with 162,425 shares worth more than $215,000. 

7. High Tide Inc. (NASDAQ:HITI)

Number of Hedge Fund Holders: 5   

Real Time Share Price as of December 26: $1.60

High Tide Inc. (NASDAQ:HITI) engages in the cannabis retail business in Canada, the United States, and internationally. In late November, High Tide Inc. (NASDAQ:HITI) announced that it had purchased certain assets of Canadian Cannabis Media related to the store located on Davie Street in Vancouver for $1.3 million. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in High Tide Inc. (NASDAQ:HITI) with 68,831 shares worth more than $127,000. 

At the end of the third quarter of 2023, 5 hedge funds in the database of Insider Monkey held stakes worth $380,000 in High Tide Inc. (NASDAQ:HITI), compared to 4 in the previous quarter worth $190,000.

6. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Hedge Fund Holders: 9

Real Time Share Price as of December 26: $0.48

Aurora Cannabis Inc. (NASDAQ:ACB) produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. In early November, Aurora Cannabis Inc. (NASDAQ:ACB) posted earnings for the second fiscal quarter, reporting a revenue of C$63 million, up over 30% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 9 hedge funds in the database of Insider Monkey held stakes worth $47.7 million in Aurora Cannabis Inc. (NASDAQ:ACB), compared to 10 in the previous quarter worth $45.7 million.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in Aurora Cannabis Inc. (NASDAQ:ACB) with 1.6 million shares worth more than $945,000. 

In addition to Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON), Aurora Cannabis Inc. (NASDAQ:ACB) is one of the cheap pot stocks to buy. 

Click to continue reading and see 5 Cheap Pot Stocks to Buy.

Suggested Articles:

Disclose. None. 11 Cheap Pot Stocks to Buy is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!